{"title":"阿纳曲唑与他莫昔芬在绝经后接受乳房肿瘤切除术加放疗(NSABP B-35)的原位导管癌患者中的疗效:一项随机、双盲、3期临床试验","authors":"L.J. Solin MD, FACR, FASTRO","doi":"10.1016/j.breastdis.2016.07.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9266,"journal":{"name":"Breast Diseases: A Year Book Quarterly","volume":"27 3","pages":"Pages 195-196"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.breastdis.2016.07.008","citationCount":"0","resultStr":"{\"title\":\"Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial\",\"authors\":\"L.J. Solin MD, FACR, FASTRO\",\"doi\":\"10.1016/j.breastdis.2016.07.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9266,\"journal\":{\"name\":\"Breast Diseases: A Year Book Quarterly\",\"volume\":\"27 3\",\"pages\":\"Pages 195-196\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.breastdis.2016.07.008\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Diseases: A Year Book Quarterly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1043321X16300704\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Diseases: A Year Book Quarterly","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043321X16300704","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial